Olorofim
CAS No. 1928707-56-5
Olorofim ( —— )
产品货号. M34247 CAS No. 1928707-56-5
Olorofim(F-901318)is a novel selective antifungal compound targeting pyrimidine biosynthesis in mycobacteria, with inhibitory effect on Aspergillus fumigatus DHODH (IC50: 44 nM), but little inhibitory effect on human DHODH (>100 uM).Olorofim has good efficacy against a variety of pathogenic filamentous and dimorphic fungi, such as Penicillium spp, P. dermatitidis spp and Fusarium spp.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥6071 | 有现货 |
|
| 10MG | ¥8246 | 有现货 |
|
| 25MG | ¥11625 | 有现货 |
|
| 50MG | ¥14787 | 有现货 |
|
| 100MG | ¥17640 | 有现货 |
|
| 500MG | ¥35280 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Olorofim
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Olorofim(F-901318)is a novel selective antifungal compound targeting pyrimidine biosynthesis in mycobacteria, with inhibitory effect on Aspergillus fumigatus DHODH (IC50: 44 nM), but little inhibitory effect on human DHODH (>100 uM).Olorofim has good efficacy against a variety of pathogenic filamentous and dimorphic fungi, such as Penicillium spp, P. dermatitidis spp and Fusarium spp.
-
产品描述Olorofim(F-901318)is a novel selective antifungal compound targeting pyrimidine biosynthesis in mycobacteria, with inhibitory effect on Aspergillus fumigatus DHODH (IC50: 44 nM), but little inhibitory effect on human DHODH (>100 uM).Olorofim has good efficacy against a variety of pathogenic filamentous and dimorphic fungi, such as Penicillium spp, P. dermatitidis spp and Fusarium spp.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Metabolic Enzyme/Protease
-
靶点Dehydrogenase
-
受体Dehydrogenase | Antifungal
-
研究领域——
-
适应症——
化学信息
-
CAS Number1928707-56-5
-
分子量498.55
-
分子式C28H27FN6O2
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESC(C(NC1=CC=C(C=C1)N2CCN(CC2)C=3N=CC(F)=CN3)=O)(=O)C4=C(C=C(C)N4C)C5=CC=CC=C5
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
DHODH-IN-23
DHODH-IN-23 (Compound A) 是一种具有口服活性的 DHODH 抑制剂,可用于癌症的研究。
-
G6PDi-1 B
G6PDi-1 是一种可逆的非竞争性6-磷酸葡萄糖脱氢酶 (G6PD) 抑制剂,对人 G6PD IC50 为 0.07 μM。G6PDi-1 最强烈地消耗淋巴细胞中的 NADPH。G6PDi-1 显着降低 T 细胞中炎性细胞因子的产生。
-
11β-HSD1-IN-11
11β-HSD1-IN-11 (Compound c1a) 是一种竞争性的 11β-HSD1 抑制剂,对大鼠和人的 11β-HSD1 的 IC50 分别为 0.34 μM 和 0.13 μM。
021-51111890
购物车()
sales@molnova.cn

